carotenoid/inflammation

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention generally relates to the fields of medicinal and synthetic chemistry. More specifically, the invention relates to the synthesis and use of carotenoid analogs or derivatives. 2. Description of the Relevant Art Recent studies have

TECHNICAL FIELD The present disclosure relates to preterm infant formulas comprising lutein, lycopene, and beta-carotene, and the use of the preterm infant formulas to modulate inflammation, such as skin inflammation, in preterm infants. BACKGROUND OF THE DISCLOSURE Dietary carotenoids are lipid

BRIEF DESCRIPTION OF THE INVENTION This invention relates to the combination of 25-hydroxyvitamin D ("25-OH D3" and/or "25-OH D2") and antioxidants/anti-inflammatories (ascorbic acid, Vitamin E and a carotenoid) for use in human nutraceuticals, pharmaceuticals and food supplements. This combination

BRIEF DESCRIPTION OF THE INVENTION This invention relates to the combination of 25-hydroxyvitamin D ("25-OH D3" and/or "25-OH D2") and antioxidants/anti-inflammatories (ascorbic acid, Vitamin E and a carotenoid) for use in bovine feed. This combination of nutritional supplements can contribute to

BACKGROUND OF THE INVENTION 1. Field of the Invention This application is a 371 of PCT/EP96/00381 filed on Feb. 2, 1996. The present invention relates to the use of carotenoids for producing drugs for the treatment of inflammatory disorders not caused by an infection with microorganisms or by the

FIELD OF THE DISCLOSURE The present disclosure is directed to the use of reduced calorie infant formulas including nucleotides and/or carotenoids for reducing long term adverse health effects, including obesity, later in life. Also disclosed are reduced calorie, reduced protein infant formulas

TECHNICAL FIELD The current invention, according to some embodiments, relates to methods of using antioxidant compositions to prevent, reduce, or eliminate the negative effects of oxidative damage or inflammation. In particular embodiments, the antioxidant compositions may be used with soft oral

FIELD OF THE INVENTION This patent relates to the general field of therapeutic products and methods to inhibit certain disease states related to the general medical field of human and veterinary pharmacology wherein the activation of the lipoxygenase pathways contribute to the pathological

FIELD OF THE INVENTION The present invention relates to methods and compositions for treatment and prevention of disease, and in particular embodiments, disorders of the eye. In an embodiment, the present invention describes linking therapeutic compounds to xanthophyll carotenoids to enhance

TECHNICAL FIELD The present application relates generally to dietary supplements and, more particularly, to dietary supplements containing a fullerene complex that may decrease multi-system symptoms of inflammation and aging in vivo. BACKGROUND The "old paradigm" of disease management reflects a

CROSS REFERENCE TO RELATED APPLICATIONS This application is a national phase application under 35 U.S.C. .sctn.371 that claims priority to PCT Application No. PCT/GB2012/053126 filed on Dec. 13, 2012, which claims the benefit of Great Britain Application No. 1121519.1 filed Dec. 14, 2011, both of

FIELD OF THE DISCLOSURE The present disclosure relates to human milk oligosaccharides (HMOs) for modulating inflammation in an infant, toddler, or child. More particularly, the present disclosure relates to human milk fortifiers, preterm and term infant formulas and pediatric formulas comprising

FIELD OF THE DISCLOSURE The present disclosure relates to human milk oligosaccharides (HMOs) for modulating inflammation in an infant, toddler, or child. More particularly, the present disclosure relates to human milk fortifiers, preterm and term infant formulas and pediatric formulas comprising

FIELD OF THE DISCLOSURE The present disclosure relates to human milk oligosaccharides (HMOs) for modulating inflammation in an infant, toddler, or child. More particularly, the present disclosure relates to human milk fortifiers, preterm and term infant formulas and pediatric formulas comprising

TECHNICAL FIELD This invention relates to pharmaceutical compositions, as well as methods, to protect skin from the armful effects of sunlight. BACKGROUND OF THE INVENTION The skin is the most environmentally-stressed organ in mammals, particularly in humans. Not only is the skin subjected to toxic